Trademark: 88323905
Status Date
Tuesday, June 2, 2020
Filing Date
Monday, March 4, 2019
Abandoned Date
Friday, April 10, 2020
5 Pain relief medication that consists of Lidocaine HCI and sold under the prescription of a physician or over the counter by chemists
Jun 2, 2020
Abandonment Notice E-Mailed - Failure To Respond
Jun 2, 2020
Abandonment - Failure To Respond Or Late Response
May 28, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
May 28, 2020
Teas Change Of Correspondence Received
May 28, 2020
Teas Change Of Owner Address Received
Oct 9, 2019
Notification Of Final Refusal Emailed
Oct 9, 2019
Final Refusal E-Mailed
Oct 9, 2019
Final Refusal Written
Sep 23, 2019
Teas/Email Correspondence Entered
Sep 23, 2019
Correspondence Received In Law Office
Sep 23, 2019
Teas Response To Office Action Received
May 17, 2019
Notification Of Non-Final Action E-Mailed
May 17, 2019
Non-Final Action E-Mailed
May 17, 2019
Non-Final Action Written
May 13, 2019
Assigned To Examiner
Mar 21, 2019
New Application Office Supplied Data Entered In Tram
Mar 7, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
